Modeling smoking cessation data with alternating states and a cure fraction using frailty models

Statistics in Medicine

Volumn 29, Issue 6, 2010, Pages 627-638

  Li, Yimei ^a   Wileyto, E Paul ^a   Heitjan, Daniel F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Addiction; Copula; Frailty model; Multiple events; Recurrent events

Indexed keywords

AMFEBUTAMONE; PLACEBO;

ARTICLE; DATA ANALYSIS; PROBABILITY; SIMULATION; SMOKING CESSATION; STATISTICAL MODEL; SURVIVAL; TOBACCO DEPENDENCE;

BEHAVIOR, ADDICTIVE; HUMANS; MODELS, STATISTICAL; RECURRENCE; SMOKING CESSATION;

EID: 77649214259     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3825     Document Type: Article

References (48)

1. U.S. Department of Health and Human Services. The health benefits of smoking cessation. DHHS Publication No. (CDC) 90-8416, USDHHS, PHS, CDC, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1990.
2. Cook RJ, Kalbfleisch JD, Yi GY. A generalized mover-stayer model for panel data. Biostatistics 2002; 3:407-420.
3. Mannan HR, Koval JJ. Latent mixed Markov modelling of smoking transition using Monte Carlo bootstrapping. Statistical Methods in Medical Research 2003; 12:125-246.
4. Banerjee S, Carlin, BP. Parametric spatial cure rate models for interval-censored time-to-relapse data. Biometrics 2004; 60:268-275.
5. Yu B, Peng Y. Mixture cure models for multivariate survival data. Computational Statistics and Data Analysis 2008; 52:1524-1532.
6. Luo S, Crainiceanu CM, Louis TA, Chatterjee N. Analysis of smoking cessation patterns using a stochastic mixed-effects model with a latent cured state. Journal of the American Statistical Association 2008; 103:1002-1013.
7. Hosmer DW, Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data. Wiley: New York, 1999.
8. Kelly PJ, Lim LL. Survival analysis for recurrent event data: an application to childhood infectious diseases. Statistics in Medicine 2000; 19:13-33.
9. Andersen PK, Borgan O, Grill RD, Keilding. Statistical Models Based on Counting Process. Springer: New York, 1993.
10. Therneau TM, Hamilton SA. rhDNase as an example of recurrent event analysis. Statistics in Medicine 1997; 16:2029-2047.
11. Withers HR, Peters LJ, Taylor JM, Owen JB, Morrison WH, Schultheiss TE, Keane T, O'Sullivan B, van Dyk J, Gupta N. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. International Journal of Radiation Oncology, Biology, Physics 1995; 33:548-562.
12. Farewell VT. The use of mixture models for the analysis of survival data with long-term survivors. Biometrics 1983; 38:1041-1046.
13. Kuk AYC, Chen CH. A mixture model combining logistic regression with proportional hazards regression. Biometrika 1992; 79:531-541.
14. Peng Y, Dear KBG, Denham JW. A generalized F mixture model for cure rate estimation. Statistics in Medicine 1998; 17:813-830.
15. Peng Y, Carriere KC. An empirical comparison of parametric and semiparametric cure models. Biometrical Journal 2002; 44:1002-1014.
16. Sy JP, Taylor JMG. Estimation in a Cox proportional hazards cure model. Biometrics 2000; 56:227-236.
17. Li CS, Taylor JMG. A semi-parametric accelerated failure time cure model. Statistics in Medicine 2002; 21:3235-3247.
18. Vaupel JW, Manton KG, Stallard E. The impact of heterogeneity in individual frailty and the dynamics of mortality. Demography 1979; 16:439-454.
19. Duchateau L, Janssen P. The Frailty Model. Springer: New York, 2008.
20. Hougaard P. Survival models for heterogeneous populations derived from stable distributions. Biometrika 1986; 71:75-83.
21. Hougaard P. Heterogeneity models of disease susceptibility, with application to diabetic nephropathy. Biometrics 1994; 50:1178-1188.
22. Aalen OO. Heterogeneity in survival analysis. Statistics in Medicine 1988; 7:1121-1137.
23. Aalen OO. Modelling heterogeneity in survival analysis by the compound Poisson distribution. Annals of Applied Probability 1992; 2:951-972.
24. Longini IM, Halloran ME. A frailty mixture model for estimating vaccine efficacy. Applied Statistics 1996; 45:165-173.
25. Price DL, Manatunga AK. Modelling survival data with a cured fraction using frailty models. Statistics in Medicine 2001; 20:1515-1527.
26. Chen MH, Ibrahim JG, Sinha D. A new Bayesian model for survival data with a surviving fraction. Journal of the American Statistical Association 1999; 94:909-919.
27. Chen MH, Ibrahim JG, Sinha D. Bayesian inference for multivariate survival data with a cure fracture. Journal of Multivariate Analysis 2002; 80:101-126.
28. Yin G. Bayesian cure rate frailty modes with application to a root canal therapy study. Biometrics 2005; 61:552-558.
29. Yin G, Ibrahim JG. A class of Bayesian shared gamma frailty models with multivariate failure time data. Biometrics 2005; 61:208-216.
30. Hougaard P. Analysis of Multivariate Survival Data. Springer: New York, 2000.
31. Smith OE, Adelfang SI, Tubbs JD. A bivariate Gamma probability distribution with application to gust model. NASA Technical Memorandum 82483, National Aeronautics and Space Administration, 1982.
32. Clayton DG. A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence. Biometrika 1978; 65:141-152.
33. Abramowitz M, Stegun I. Handbook of Mathematical Functions. Dover: New York, 1972.
34. Nelson KP, Lipsitz SR, Fitzmaurice GM, Ibrahim J, Parzen M, Strawderman R. Use of the probability integral transformation to fit nonlinear mixed-effects models with nonnormal random effects. Journal of Computational and Graphical Statistics 2006; 15:39-57.
35. Liu L, Huang X. The use of Gaussian quadrature for estimation in frailty proportional hazards models. Statistics in Medicine 2007; 27:2665-2683.
36. Liu L, Yu Z. A likelihood reformulation method in non-normal random effects models. Statistics in Medicine 2008; 27:3105-3124.
37. Dennis JE, Schnabel RB. Numerical Methods for Unconstrained Optimization and Nonlinear Equations. Prentice-Hall: Englewood Cliffs, NJ, 1983.
38. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Chapman & Hall: London, 1993.
39. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics 2000; 56:645-646.
40. Huang Y, Chen YQ. Marginal regression of gaps between recurrent events. Lifetime Data Analysis 2003; 9:293-303.
41. Chen YQ, Wang MC, Huang Y. Semiparametric regression analysis on longitudinal pattern of recurrent gap times. Biostatistics 2004; 5:277-290.
42. Heitjan DF, Rubin DB. Ignorability and coarse data. The Annals of Statistics 1991; 19:2244-2253.
43. Heitjan DF. Ignorability and coarse data: some biomedical examples. Biometrics 1993; 49:1099-1109.
44. Heitjan DF. Ignorability in general incomplete-data models. Biometrika 1994; 81:701-708.
45. Lerman C, Roth D, Kaufmann V, Audrain J, Hawk L, Liu A, Niaura R, Epstein L. Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug and Alcohol Dependence 2002; 67:219-223.
46. Brown RA, Niaura R, Lloyd-Richardson EE, Strong DR, Kahler CW, Abrantes AM, Abrams D, Miller IW. Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine and Tobacco Research 2007; 9:721-730.
47. Wileyto EP, Patterson F, Niaura R, Epstein LH, Brown RA, Audrain-McGovern J, Hawk LW, Lerman C. Recurrent event analysis of laps and recovery in a smoking cessation clinical trial using bupropion. Nicotine and Tobacco Research 2005; 7(2):257-268.
48. Yan J. Enjoy the joy of copulas: with a package copula. Journal of Statistical Software 2007; 21(4).